Cell-based therapy in ischemic stroke

References

• Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov.7(1), 21–39 (2008).
   PubMed Web of Science ®Google Scholar
• Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat. Med.14(5), 504–506 (2008).
   PubMed Web of Science ®Google Scholar
• Nadal-Ginard B, Fuster V. Myocardial cell therapy at the crossroads. Nat. Clin. Pract. Cardiovasc. Med.4(1), 1 (2007).
   PubMedGoogle Scholar
• Cardiac cell therapy: bench or bedside? Nat. Clin. Pract. Cardiovasc. Med.4(8), 403 (2007).
   PubMedGoogle Scholar
• Bath PM, Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst. Rev.3, CD005207 (2006).
   Google Scholar
• Schneider A, Kuhn HG, Schabitz WR. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle4(12), 1753–1757 (2005).
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Wechsler L, Goldstein S et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology55(4), 565–569 (2000).
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Steinberg GK, Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial. J. Neurosurg.103(1), 38–45 (2005).
   PubMed Web of Science ®Google Scholar
• Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc. Dis.20(2), 101–107 (2005).
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol.57(6), 874–882 (2005).
   PubMed Web of Science ®Google Scholar
• Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol.213(2), 341–347 (2007).
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci.189(1–2), 49–57 (2001).
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang ZG, Li Y et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res.92(6), 692–699 (2003).
   PubMed Web of Science ®Google Scholar
• Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol.1(2), 92–100 (2002).
   PubMed Web of Science ®Google Scholar
• Li Y, Chen J, Wang L, Lu M, Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology56(12), 1666–1672 (2001).
   PubMed Web of Science ®Google Scholar
• Li Y, Chopp M, Chen J et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J. Cereb. Blood Flow Metab.20(9), 1311–1319 (2000).
   PubMed Web of Science ®Google Scholar
• Shen LH, Li Y, Chen J et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. Blood Flow Metab.27(1), 6–13 (2007).
   PubMed Web of Science ®Google Scholar
• Li Y, Chen J, Zhang CL et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia49(3), 407–417 (2005).
   PubMed Web of Science ®Google Scholar
• Shen LH, Li Y, Chen J et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience137(2), 393–399 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang C, Li Y, Chen J et al. Bone marrow stromal cells upregulate expression of bone morphogenetic proteins 2 and 4, gap junction protein connexin-43 and synaptophysin after stroke in rats. Neuroscience141(2), 687–695 (2006).
   PubMed Web of Science ®Google Scholar
• Chen J, Sanberg PR, Li Y et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke32(11), 2682–2688 (2001).
   PubMed Web of Science ®Google Scholar
• Newcomb JD, Ajmo CT Jr, Sanberg CD et al. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant.15(3), 213–223 (2006).
   PubMed Web of Science ®Google Scholar
• Vendrame M, Cassady J, Newcomb J et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke35(10), 2390–2395 (2004).
   PubMed Web of Science ®Google Scholar
• Taguchi A, Soma T, Tanaka H et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest.114(3), 330–338 (2004).
   PubMed Web of Science ®Google Scholar
• Willing AE, Lixian J, Milliken M et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res.73(3), 296–307 (2003).
   PubMed Web of Science ®Google Scholar
• Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke35(10), 2385–2389 (2004).
   PubMed Web of Science ®Google Scholar
• Vendrame M, Gemma C, Pennypacker KR et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol.199(1), 191–200 (2006).
   PubMed Web of Science ®Google Scholar
• Makinen S, Kekarainen T, Nystedt J et al. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res.1123(1), 207–215 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature418(6893), 41–49 (2002).
   PubMed Web of Science ®Google Scholar
• Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol.174(1), 11–20 (2002).
   PubMed Web of Science ®Google Scholar
• Yasuhara T, Matsukawa N, Yu G et al. Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus. Rev. Neurosci.17(1–2), 215–225 (2006).
   PubMed Web of Science ®Google Scholar
• Yasuhara T, Matsukawa N, Yu G et al. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant.15(3), 231–238 (2006).
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood110(10), 3499–3506 (2007).
   PubMed Web of Science ®Google Scholar
• Stroemer P, Hope A, Patel S, Pollock K, Sinden J. Development of a human neural stem cell line for use in recovery from disability after stroke. Front. Biosci.13, 2290–2292 (2008).
   PubMed Web of Science ®Google Scholar
• Pollock K, Stroemer P, Patel S et al. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurol.199(1), 143–155 (2006).
   PubMed Web of Science ®Google Scholar
• Dezawa M, Kanno H, Hoshino M et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest.113(12), 1701–1710 (2004).
   PubMed Web of Science ®Google Scholar
• Mimura T, Dezawa M, Kanno H, Yamamoto I. Behavioral and histological evaluation of a focal cerebral infarction rat model transplanted with neurons induced from bone marrow stromal cells. J. Neuropathol. Exp. Neurol.64(12), 1108–1117 (2005).
   PubMed Web of Science ®Google Scholar
• Parolini O, Alviano F, Bagnara GP et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells26(2), 300–311 (2008).
   PubMed Web of Science ®Google Scholar
• De Coppi P, Bartsch G Jr, Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol.25(1), 100–106 (2007).
   PubMed Web of Science ®Google Scholar
• Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp. Neurol.183(2), 355–366 (2003).
   PubMed Web of Science ®Google Scholar
• Wei L, Cui L, Snider BJ et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol. Dis.19(1–2), 183–193 (2005).
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J. Cell Biochem.98(5), 1076–1084 (2006).
   PubMed Web of Science ®Google Scholar
• Ringden O, Uzunel M, Rasmusson I et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation81(10), 1390–1397 (2006).
   PubMed Web of Science ®Google Scholar
• Hill WD, Hess DC, Martin-Studdard A et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol.63(1), 84–96 (2004).
   PubMed Web of Science ®Google Scholar
• Imitola J, Raddassi K, Park KI et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl Acad. Sci. USA101(52), 18117–18122 (2004).
   PubMed Web of Science ®Google Scholar
• Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol.20(11), 1111–1117 (2002).
   PubMed Web of Science ®Google Scholar
• Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. N. Engl. J. Med.355(16), 1730–1735 (2006).
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1199–1209 (2006).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1210–1221 (2006).
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med.355(12), 1222–1232 (2006).
   PubMed Web of Science ®Google Scholar
• Cramer SC, Koroshetz WJ, Finklestein SP. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke38(4), 1393–1395 (2007).
   PubMed Web of Science ®Google Scholar
• Hicks AU, Hewlett K, Windle V et al. Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke. Neuroscience146(1), 31–40 (2007).
   PubMed Web of Science ®Google Scholar
• Dahlqvist P, Ronnback A, Bergstrom SA, Soderstrom I, Olsson T. Environmental enrichment reverses learning impairment in the Morris water maze after focal cerebral ischemia in rats. Eur. J. Neurosci.19(8), 2288–2298 (2004).
   PubMed Web of Science ®Google Scholar
• Nygren J, Wieloch T. Enriched environment enhances recovery of motor function after focal ischemia in mice, and downregulates the transcription factor NGFI-A. J. Cereb. Blood Flow Metab.25(12), 1625–1633 (2005).
   PubMed Web of Science ®Google Scholar
• Komitova M, Mattsson B, Johansson BB, Eriksson PS. Enriched environment increases neural stem/progenitor cell proliferation and neurogenesis in the subventricular zone of stroke-lesioned adult rats. Stroke36(6), 1278–1282 (2005).
   PubMed Web of Science ®Google Scholar
• Dobrossy MD, Dunnett SB. Optimising plasticity: environmental and training associated factors in transplant-mediated brain repair. Rev. Neurosci.16(1), 1–21 (2005).
   PubMed Web of Science ®Google Scholar
• Wolf SL, Winstein CJ, Miller JP et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA296(17), 2095–2104 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang Q, Zhang ZG, Ding GL et al. MRI detects white matter reorganization after neural progenitor cell treatment of stroke. Neuroimage32(3), 1080–1089 (2006).
   PubMed Web of Science ®Google Scholar
• Lindberg PG, Skejo PH, Rounis E et al. Wallerian degeneration of the corticofugal tracts in chronic stroke: a pilot study relating diffusion tensor imaging, transcranial magnetic stimulation, and hand function. Neurorehabil. Neural Repair21(6), 551–560 (2007).
   PubMed Web of Science ®Google Scholar
• Stinear CM, Barber PA, Smale PR, Coxon JP, Fleming MK, Byblow WD. Functional potential in chronic stroke patients depends on corticospinal tract integrity. Brain130(Pt 1), 170–180 (2007).
   PubMed Web of Science ®Google Scholar
• Lai C, Zhang SZ, Liu HM et al. White matter tractography by diffusion tensor imaging plays an important role in prognosis estimation of acute lacunar infarctions. Br. J. Radiol.80(958), 782–789 (2007).
   PubMed Web of Science ®Google Scholar
• Cramer SC, Parrish TB, Levy RM et al. Predicting functional gains in a stroke trial. Stroke38(7), 2108–2114 (2007).
   PubMed Web of Science ®Google Scholar
• Manganas LN, Zhang X, Li Y et al. Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science318(5852), 980–985 (2007).
   PubMed Web of Science ®Google Scholar
• Chemaly ER, Yoneyama R, Frangioni JV, Hajjar RJ. Tracking stem cells in the cardiovascular system. Trends Cardiovasc. Med.15(8), 297–302 (2005).
   PubMed Web of Science ®Google Scholar
• Neri M, Maderna C, Cavazzin C et al. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells26(2), 505–516 (2007).
   PubMed Web of Science ®Google Scholar
• Tolar J, Nauta AJ, Osborn MJ et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells25(2), 371–379 (2007).
   PubMed Web of Science ®Google Scholar
• Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet362(9385), 697–703 (2003).
   PubMed Web of Science ®Google Scholar
• Liu H, Honmou O, Harada K et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain129(Pt 10), 2734–2745 (2006).
   PubMed Web of Science ®Google Scholar
• Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience136(1), 161–169 (2005).
   PubMed Web of Science ®Google Scholar